Skip to main content

Advertisement

ADVERTISEMENT

SmartTrak x Wound Care Collaboration News

News
08/08/2024
Avita enters into an exclusive 5-year development and distribution agreement with Regenity Biosciences for a unique collagen-based dermal matrix. Upon 510(k) clearance expected Q424, Avita will make an initial $2.0MM payment followed by...
Avita enters into an exclusive 5-year development and distribution agreement with Regenity Biosciences for a unique collagen-based dermal matrix. Upon 510(k) clearance expected Q424, Avita will make an initial $2.0MM payment followed by...
Avita enters into an exclusive...
08/08/2024
Wound Care
News
08/08/2024
MiMedx announces the launch of its first xenograft product, HELIOGEN, a particulate fibrillar bovine collagen matrix for addressing complex wounds primarily in the surgical setting.
MiMedx announces the launch of its first xenograft product, HELIOGEN, a particulate fibrillar bovine collagen matrix for addressing complex wounds primarily in the surgical setting.
MiMedx announces the launch of...
08/08/2024
Wound Care
News
08/08/2024
Polaroid Therapeutics announced its partnership with Speciality Fibres and Materials Ltd to test a novel wound dressing that prevents infection and aids healing. The trials aim to create a breakthrough in advanced wound care, particularly for...
Polaroid Therapeutics announced its partnership with Speciality Fibres and Materials Ltd to test a novel wound dressing that prevents infection and aids healing. The trials aim to create a breakthrough in advanced wound care, particularly for...
Polaroid Therapeutics announced...
08/08/2024
Wound Care

Advertisement

News
08/08/2024
MiMedx management noted that the increase in revenue was partially offset by commercial challenges due to sales of artificially high-priced skin substitute products by competitors, the uncertainty of Medicare reimbursements and sales team...
MiMedx management noted that the increase in revenue was partially offset by commercial challenges due to sales of artificially high-priced skin substitute products by competitors, the uncertainty of Medicare reimbursements and sales team...
MiMedx management noted that the...
08/08/2024
Wound Care
News
08/08/2024
Results of a 196-patient RCT comparing the efficacy of ExcharEx for debridement of VLUs vs placebo (GV) and nonsurgical SoC (NSSOC) showed a significantly higher incidence of complete debridement at 63% compared to GV (30.2%) and NSSOC (13%),...
Results of a 196-patient RCT comparing the efficacy of ExcharEx for debridement of VLUs vs placebo (GV) and nonsurgical SoC (NSSOC) showed a significantly higher incidence of complete debridement at 63% compared to GV (30.2%) and NSSOC (13%),...
Results of a 196-patient RCT...
08/08/2024
Wound Care
News
08/08/2024
AOTI announces US FDA 510(k) Clearance for an extension of the indications for their NEXATM NPWT System. The amended indications, "for use in acute, extended and home care settings…," will allow the device to be marketed to additional care...
AOTI announces US FDA 510(k) Clearance for an extension of the indications for their NEXATM NPWT System. The amended indications, "for use in acute, extended and home care settings…," will allow the device to be marketed to additional care...
AOTI announces US FDA 510(k)...
08/08/2024
Wound Care

Advertisement

News
08/08/2024
Integra announced plans to restart the manufacture of PriMatrix and SurgiMend at its new manufacturing facility in Braintree, Massachusetts in H126. IART also noted it expects Integra Skin sales to be at normalized run rates during Q424. IART...
Integra announced plans to restart the manufacture of PriMatrix and SurgiMend at its new manufacturing facility in Braintree, Massachusetts in H126. IART also noted it expects Integra Skin sales to be at normalized run rates during Q424. IART...
Integra announced plans to...
08/08/2024
Wound Care
News
08/08/2024
In H224, Convatec expects to further grow sales of InnovaMatrix by pursuing other indications and by starting the launch of InnovaMatrix outside of the US. In addition, RCT’s are to be initiated for VLUs and DFUs in Q324. CTEC H124 Earnings...
In H224, Convatec expects to further grow sales of InnovaMatrix by pursuing other indications and by starting the launch of InnovaMatrix outside of the US. In addition, RCT’s are to be initiated for VLUs and DFUs in Q324. CTEC H124 Earnings...
In H224, Convatec expects to...
08/08/2024
Wound Care
News
07/30/2024
BioStem Technologies initiated a 60-patient RCT to evaluate the safety and efficacy of AmnioWrap2 plus SoC vs SoC only for treatment of DFUs with primary outcome of % of wound closure over 12 weeks. Not yet recruiting; estimated study...
BioStem Technologies initiated a 60-patient RCT to evaluate the safety and efficacy of AmnioWrap2 plus SoC vs SoC only for treatment of DFUs with primary outcome of % of wound closure over 12 weeks. Not yet recruiting; estimated study...
BioStem Technologies initiated a...
07/30/2024
Wound Care

Advertisement

News
07/30/2024
Surgenex has initiated a 180-patient RCT comparing Pellograft for treatment of DFUs and SanoGraft for treatment of VLUs vs SoC with primary outcome of 100% epithelialization of DFUs at 12 weeks and VLUs at 16 weeks. Recruitment has begun with...
Surgenex has initiated a 180-patient RCT comparing Pellograft for treatment of DFUs and SanoGraft for treatment of VLUs vs SoC with primary outcome of 100% epithelialization of DFUs at 12 weeks and VLUs at 16 weeks. Recruitment has begun with...
Surgenex has initiated a...
07/30/2024
Wound Care

Advertisement